Zamorano, Rocio, Sunil Suchindran, and James V. Gainer. 3Ј-Untranslated region of the type 2 bradykinin receptor is a potent regulator of gene expression. Am J Physiol Renal Physiol 290: F456 -F464, 2006. First published September 6, 2005 doi:10.1152/ajprenal.00009.2005.-Regulation of the constitutively expressed type 2 bradykinin (B2) receptor, which mediates the principal actions of bradykinin, occurs at multiple levels. The goal of the current study was to determine whether the human B2 3Ј-untranslated region (UTR) has effects on gene expression, with particular focus on the variable number of tandem repeats (B 2-VNTR) polymorphic portion of the 3Ј-UTR and its flanking AU-rich elements (AREs). When inserted downstream of the luciferase coding region of the pGL3-Promoter vector, the B 2-VNTR reduced reporter gene activity by 85% compared with pGL3-Promoter alone (promoter control; P Ͻ 0.001), an effect that was not appreciably affected by mutation of the flanking AREs. The negative regulatory effects of the B 2-VNTR region were position and orientation dependent and strongly positively correlated with the number of tandem repeats in the B 2-VNTR region (r ϭ 0.85, P Ͻ 0.001). With respect to mechanism, quantitative RT-PCR revealed that the B 2-VNTR mRNA level was 32% of that of promoter control (P ϭ 0.008), whereas the number of polyadenylated transcripts was 4% (P ϭ 0.02). In contrast, the mRNA half-life of the B2-VNTR was increased (B 2-VNTR: 14.9 vs. promoter control: 12.2 h, P ϭ 0.009). Transient transfection of human kidney-derived tsA201 cells with the B2-VNTR construct increased transcription of the native B 2 receptor mRNA by 43% (P Ͻ 0.05), supporting an endogenous B2 receptor-regulatory capacity of the B 2-VNTR. In conclusion, these results identify novel pretranslational effects of the B2-VNTR region to act as a potent negative regulator of heterologous gene expression and support the notion that the bradykinin B 2 3Ј-UTR may impact endogenous receptor regulation. gene regulation; variable number of tandem repeats; polymorphism BRADYKININ HAS AN INTEGRAL relevance to a range of biological processes including vasodilatory control (25, 26), sodium homeostasis (1), fibrinolysis (6), thrombosis (18), pain (7, 12), allergy (19, 31) , and inflammation (7, 19) . The principal actions of bradykinin and the kinin system are mediated by the constitutively expressed type 2 (B 2 ) receptor, which has extensive tissue distribution, notably in the kidney, heart, skin, and peripheral vasculature (17, 26) . The use of bradykinin receptor antagonists specific for the B 2 receptor as well as knockout and transgenic mice has established beneficial effects of kinins to reduce blood pressure (15, 25), oppose vasoconstrictive and growth effects of ANG II (20, 35) , and stimulate fibrinolysis (6). Other studies support the involvement of the kinin system in the pathogenesis of asthma (19, 31), arthritis (10), and angioedema (19).
Several levels of regulation of the B 2 receptor have been described (4) of which receptor level regulation has been the most well characterized (30) . With respect to transcriptional control, the rat B 2 promoter has been extensively studied. Pesquero et al. (29) reported the capacity of the rat B 2 receptor to be upregulated by the action of cAMP, bradykinin, phorbol esters, and by coexpression of an activated ras oncogene. A silencer element that occurs in a putative sterol responsive element (SRE-1) in the rat B 2 promoter has been associated with a cell-specific downregulation of the B 2 receptor (2). Marks et al. (27) demonstrated that p53 acts on an upstream sequence-specific transcriptional enhancer in the rat B 2 promoter, which is conserved in rats and humans. The finding of B 2 receptor upregulation which is dependent on the tumor suppressor protein, 53, suggests the importance of transcriptional control of the rat B 2 receptor in renal epithelial cell development (13) . In a recent study, Saifudeen et al. (14, 33) demonstrated the complexity of the p53 regulation of the B 2 receptor by showing that p53 can physically interact with both cAMP response element binding protein (CREB) and Kruppellike factor (KLF-4) to regulate B 2 promoter function in the developing kidney.
Whether significant posttranscriptional aspects of B 2 regulation exist is less well studied (4, 30) , whereas the 3Ј-untranslated region (UTR) mediates significant posttranscriptional regulation of the B 1 receptor, largely through a reduction of stability of mRNA (41) . The presence of regulatory elements in the noncoding exon 1 of the human B 2 receptor has been postulated based on the finding of increased mRNA levels in subjects with a nine-base deletion variant in that region (23) . Lung et al. (24) showed that interferon-␥ caused an upregulation of bradykinin receptor mRNA and protein expression, which could be blocked by either transcriptional or protein synthesis inhibition, suggesting the existence of both transcriptional and posttranscriptional effects.
The capacity for posttranscriptional regulation of the human B 2 receptor exists by virtue of the existence of AU-rich elements (AREs) in the 3Ј-UTR, which can act in a context-specific manner to increase or decrease mRNA stability and otherwise have effects on translation (3). Specifically, two AREs which contain the core pentad, AUUUA, occur in the B 2 3Ј-UTR and are located immediately upstream and downstream of a variable number of tandem repeats (VNTR)-type polymorphism, which was previously reported by Braun et al (5) . The role of the AREs in B 2 receptor regulation has not been tested.
The goal of the current study was to determine the effects of the human B 2 3Ј-UTR on gene expression, with particular focus on the VNTR polymorphic portion (B 2 -VNTR) of the 3Ј-UTR including the flanking ARE segments. In this report, we provide evidence that the B 2 3Ј-UTR harbors a functional element within the B 2 -VNTR region that potently regulates gene expression which occurs through a non-ARE-dependent mechanism. We demonstrated that the B 2 -VNTR, which is not conserved among species, acts in a position-and orientationdependent fashion in a reporter plasmid to reduce gene expression in human and nonhuman cell lines. We further showed that the transfection of the minimal B 2 -VNTR element in a human kidney-derived cell line, which expresses the bradykinin receptor, modulates the regulation of the endogenous B 2 receptor.
MATERIALS AND METHODS

3Ј-UTR constructs.
Segments of the human B2 receptor 3Ј-UTR were PCR-amplified using oligonucleotide primers containing flanking SacII and NdeI recognition sequences. For antisense constructs, the flanking restriction endonuclease sequences for the primers were interchanged. The PCR products were gel-purified and ligated downstream of the firefly luciferase coding region of the pGL3-Promoter vector (Promega, Madison, WI). The XbaI restriction site in this vector was reengineered with a linker segment to allow unidirectional insertion of the 3Ј-UTR. The pGL3-Promoter vector backbone was chosen because it contains the SV40 promoter without enhancers; therefore, changes in luciferase activity can be attributed to the effect of 3Ј-UTR inserts. The following primers were used to amplify the B 2-VNTR region: forward: 5Ј-ctcagcaaccaagggattgt-3Ј; reverse: 5Ј-GGTCAGGATTTATGGGCTCTT-3Ј. The sequence of the most commonly occurring variant (43 repeats) of the B 2-VNTR region was used in this experiment (5) . All constructs were confirmed by direct sequencing.
Cell culture/transient transfections. Human kidney-derived tsA201 cells, a subclone of the HEK293 cell line, were cultured in a defined medium made by mixing equal parts of DMEM and Coon's modified Ham's F-12 medium, 10% fetal bovine serum, and 100 U/ml penicillin-streptomycin in a humidified chamber maintained at 37°C containing 5% CO 2. tsA201 cells were plated at 50 -60% confluence in 24-well dishes 24 h before transfection. Pilot studies were performed to optimize the ratio of DNA to the FuGENE 6 transfection agent (Roche Diagnostics, Indianapolis, IN) and demonstrate independent expression of the luciferase reporter and Renilla coreporter vector signals. For these transfections, a 3:2 ratio of FuGENE:cDNA was used. Before transfection, cells were washed three times with phosphate-buffered saline. The FuGENE-DNA mixture was divided equally among two wells, the second of which was used as a duplicate. Four-hundred microliters of serum-free DMEM were added to each well followed by incubation as described above for 4.5 h. Cells were then washed with phosphate-buffered saline and DMEM and 10% fetal bovine serum was added. Forty-eight hours later, cells were harvested and assayed for firefly and Renilla luciferase activity.
Measurement of luciferase activity. To determine whether the B 2 3Ј-UTR could confer transcriptional or posttranscriptional control of gene expression in a heterologous reporter system, we compared luciferase activity among chimeric luciferase constructs which contained either 1) the B 2-VNTR which encompasses the midsegment of the B2 3Ј-UTR and flanking class I AREs (defined as the occurrence of an AUUUA pentamer in a non-U-rich region), 2) the 3Ј-UTR from the smooth muscle myosin light chain (SMMLC) (used as a length control), or the 3) insertion-less pGL3 Promoter (designated promoter control).
Luciferase reporter assays were performed using the Dual-Glo Luciferase Reporter Assay System (Promega). At the time of harvest, the culture medium was removed, and cells were washed with phosphate-buffered saline. Passive lysis buffer (100 l of 1ϫ buffer) was added to each well, and plates were placed in a shaking incubator for 15 min at room temperature. For additional lysis, two freeze-thaw cycles were performed in which the cells were frozen to Ϫ80°C. The lysate was placed in a 96-well luminometer plate (Packard Bioscience, Billerica, MA) with an equal volume of Dual-Glo Luciferase Reagent and incubated for 10 min. Firefly luciferase luminescence was measured. Before measurement of Renilla luciferase (pRL-TK vector, Promega), 100 l of the Stop and Glo reagent (Promega) were added to each well to quench the firefly luciferase reaction. Renilla luciferase luminescence was measured after an incubation of 10 min. All luciferase measurements represent an average of readings performed in triplicate. Fresh reagents were used for entire sets of samples and their duplicates to ensure equivalent reaction conditions. Relative firefly luciferase light output was normalized by Renilla luciferase output after appropriate subtraction of background light output. In most cases, data points represent the means Ϯ SE of two or three iterations of three to seven independent experiments.
Mutation assay. In the experiments regarding the role of the AREs in gene expression, the core AUUUA pentamer of each element was altered using site-directed mutagenesis performed according to the manufacturer's instructions (Stratagene, La Jolla, CA). Mutagenesis oligonucleotide primers (1st ARE forward: 5Ј-gggcagcactcattcacttgataaatgaataGGGattagctggttgg-3Ј and 2nd ARE forward: 5Ј-gggctagaacctggagaatgagaAAGGGTtacatggcaaagagccc-3Ј; mutated bases underlined) were added to purified plasmid DNA and extended during temperature cycling using Pfu Turbo DNA polymerase. The resultant product was digested with DpnI and transformed into DH5.1-␣ cells. Mutagenesis products were confirmed by direct sequencing.
Total RNA extraction, cDNA synthesis, and quantitative PCR. The levels of chimeric luciferase transcripts were determined using real-time quantitative reverse transcriptase PCR using SYBR Green chemistry. Total RNA was extracted from tsA201 cells using TRIzol reagent (Invitrogen, Carlsbad, CA) according to instructions from the manufacturer. To eliminate amplification of reporter plasmid DNA and genomic DNA, total RNA was treated with DNase RQI (Promega, 10 U) at 37°C for 30 min, followed by reisolation of RNA with phenol/chloroform treatment. RNA (1.0 g) was reverse transcribed with SuperScript II RNase H reverse transcriptase (Invitrogen) using either random hexamer or oligo dT primers. After first-strand synthesis, the cDNA was quantified using the DNA-binding dye SYBR green I (Qiagen, Valencia, CA). Fluorescence was detected using an iCycler iQ sequence detection system (Bio-Rad, Richmond, CA). Luciferase amplification primers were forward: 5Ј-GCCTGAAGTCTCTGATTAAGT-3Ј and reverse: 5Ј-ACACCTGCGTCGAAGATGT-3Ј. Renilla luciferase primers were forward: 5Ј-ATGGGATGAATGGCCTGATA-3Ј and reverse: 5Ј-CA-ACATGGTTTCCACGAAGA-3Ј. Amplification primers for human glyceraldehyde-3-phosphate (GAPDH) were 5Ј-ACTCTGGTAAAG-TGGATATTGTTGC-3Ј for the forward primer and 5Ј-GAAGATGG-TGATGGGATTTCC-Ј3 for the reverse primer. For detection of the B2 receptor, the following primers were used: forward: 5Ј-TCAATG-TTTCTGTCTGTTCGTG-3Ј; reverse 5Ј-AAAGGTCCCGTTAAGA-GTGG-3Ј.
Melting curves were generated to maximize fluorescence from SYBR green I binding to the desired amplicon. The starting quantity (SQ) of each sample was calculated using a standard curve derived from a 1-, 9-, and 27-fold dilution series of RNA for both pGL3-Promoter without insert and Renilla luciferase. The correlation coefficient for each standard curve was greater than 0.99. Realtime PCR reactions were performed in triplicate. The SQ mean was calculated for each time point and normalized for transfection efficiency by dividing by the Renilla SQ mean from the same RNA sample.
EMSA. tsA201 nuclear and cytoplasmic extracts were prepared using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Pierce Biotechnology, Rockford, IL). RNA was generated using an in vitro transcription kit (Promega) and labeled by T4 PolyA polymerase (USB, Cleveland, OH) using biotinylated ATP. RNA was cleaned using an RNA Cleanup Kit (Qiagen) and quantified using RiboGreen (Molecular Probes, Eugene, OR). Binding was performed with 5 g of protein (nuclear or cytoplasmic) and 23.5 ng of probe in binding buffer (Promega). For competition experiments, cold B 2-VNTR or nonspecific competitor was added in 10 -25 ϫ molar excess to protein extracts and incubated for 20 min followed by the addition of labeled probe and incubated 20 additional min on ice. Complexes were resolved using 5% polyacrylamide electrophoresis, and gel was transferred to a positively charged nylon membrane. Chemiluminescent signals were detected using BrightStar BioDetect (Ambion, Austin, TX) after X-ray film exposure.
Statistical analysis. Differences in luciferase activity were compared using 2 , Mann-Whitney, or general linear models with repeated-measures testing, where appropriate. All statistical tests were two-sided, and a value of P Ͻ 0.05 was considered statistically significant. Fig.  1 , the B 2 -VNTR contains the purine-rich tandem repeats polymorphism which is composed of four alleles, the most common of which is the 43-repeat allele (5), and also includes the flanking class I flanking AREs which contain the core AUUUA pentad (upstream: AAUAUUUAUUA; downstream: AAAAUUUACAU). With respect to species conservation, the B 2 -VNTR segment is also found in the chimpanzee (P. troglodytes) and contains 32 repeats but otherwise shows little conservation among species ( Table 1 ), such that no identifiable VNTR exists in the B 2 3Ј-UTR for the rat (R. norvegicus), mouse (M. musculus), or dog (C. familiaris). In humans and chimpanzees, the B 2 -VNTR segment is a purine-rich pocket (68 and 64%, respectively) in the 3Ј-UTR which otherwise has a purine percentage of 54%. Despite the lack of sequence identity in the B 2 3Ј-UTR among species with respect to the VNTR, a purine-rich tandem repeat structure with considerable similarity to the B 2 -VNTR was identified in the rat, mouse, and dog in alternate chromosomal locations (Table 2) .
RESULTS
Characteristics of the B 2 -VNTR region. As shown in
B 2 3Ј-UTR is a potent regulator of gene expression. The tsA201 cells were transiently transfected with luciferase vectors (pGL3-Promoter) in which the B 2 -VNTR or SMMLC 3Ј-UTRs were inserted downstream of the luciferase coding region. Renilla-normalized luciferase activity for each construct was compared with the insertion-less pGL3-Promoter vector (promoter control). As shown in Fig. 2 , the construct containing the B 2 -VNTR reduced luciferase expression by 85% compared with promoter control (Ϫ85 Ϯ 1%, Z ϭ Ϫ4.4, P Ͻ 0.001). Gene expression of the construct containing the SMMLC 3Ј-UTR, used as a length control, was increased over that of promoter control (31 Ϯ 1%; Z ϭ Ϫ4.0, P Ͻ 0.001).
AREs in the B 2 3Ј-UTR do not affect gene expression. To determine the importance of the AREs to gene expression, one or both AREs were mutated by site-directed mutagenesis. As shown in Fig. 3 , compared with the nonmutated B 2 -VNTR construct, normalized luciferase activity was minimally different for constructs in which the first (difference ϭ Ϫ2%, Z ϭ Ϫ2.9, P ϭ 0.004) or both AREs were mutated (difference ϭ Ϫ3%, Z ϭ Ϫ2.9, P ϭ 0.004). These data suggest that the AREs do not have appreciable functional effects on gene expression in the context of the B 2 3Ј-UTR.
Effects of B 2 -VNTR on gene expression are position and orientation dependent. To assess whether the B 2 -VNTR region could operate in the inverse orientation, the reverse complement of the B 2 -VNTR segment was cloned into the pGL3-Promoter vector downstream of the luciferase coding region (B 2 -VNTR-INVERSE). This construct reduced luciferase activity to 56% of promoter control (P Ͻ 0.001) or approximately two-thirds of the reduction attributable to the sense orientation of the B 2 -VNTR construct (Fig. 4) .
To determine whether the location of the B 2 -VNTR in the luciferase reporter plasmid influenced its capacity to alter reporter gene expression, both the B 2 -VNTR and B 2 -VNTR-INVERSE segments were inserted into the multiple cloning region (MCR) adjacent to the SV40 promoter of the pGL3-Promoter vector. As shown in Fig. 4 , transcription attributable to these constructs was not significantly different from that of Shown are the species, chromosomal location, and the NCBI reference sequence (RefSeq) number for the B2 receptor, and the length of the B2 3Ј-UTR defined as the number of base pairs from the terminal codon to the putative polyadenylation site. In humans and chimpanzees, properties of the VNTR occurring in the B2 3Ј-UTR are shown. Shown are the species, chromosomal location, and tandem repeat sequence and number of repeats for a tandem repeat structure similar to the B2-VNTR but not located within the B2 3Ј-UTR.
promoter control, nor was there a difference when the B 2 -VNTR was inserted in a position downstream of the SV40 late polyA signal in the pGL3-Promoter vector (Fig. 4) . These results support that contention that the effects of the B 2 -VNTR on transcription are strictly position dependent but are also orientation dependent such that the maximal effect is observed in the sense orientation.
Multiple cis-elements are associated with a reduction in gene expression by the B 2 3Ј-UTR. To test the hypothesis that cis-acting elements, other than the AREs, within the B 2 -VNTR region mediated the effects on gene expression, we compared luciferase expression among a series of 3Ј-UTR deletion constructs (Fig. 5) . The maximal reduction of gene expression was observed with the B 2 -VNTR, which includes upstream and downstream flanking regions. The upstream flanking region tested alone significantly reduced gene expression (Ϫ58%; Z ϭ Ϫ3.1; P ϭ 0.002), whereas the effect of the downstream flanking region was modest (Ϫ27%; Z ϭ Ϫ3.1; P ϭ 0.002) compared with promoter control. The number of tandem repeats in the B 2 -VNTR region correlated positively with the reduction in gene expression (r ϭ 0.85, P Ͻ 0.001). Taken together, these data support the presence of elements both within and upstream of the B 2 -VNTR region that reduce gene expression but suggest that the regulatory potential of this region depends on a critical number of tandem repeats. Fig. 2 . Effect of B2 3Ј-untranslated region (UTR) on luciferase reporter gene expression. B2 3Ј-UTR constructs containing either the B2-VNTR (variable number of tandem repeats) region or the smooth muscle myosin light chain 3Ј-UTR (SMMLC; used as a length control, 850 nt) were compared with pGL3-P (promoter control vector without insert). Luminometer measurements (ϮSE) for this and subsequent experiments are expressed as fold of promoter control in relative light units of firefly luciferase normalized by Renilla luciferase (index of transfection efficiency) and represent an average of 2-7 independent experiments performed in duplicate for each construct with luciferase activity measured in triplicate. Fig. 3 . Effect of ARE on gene expression. Reporter gene expression was compared between B2-VNTR constructs in which none, one, or both ARE sequences were mutated. B 2 -VNTR is associated with reduced mRNA levels but not accelerated mRNA degradation. To determine whether accelerated mRNA decay can contribute to the observed reduction in luciferase activity associated with the B 2 -VNTR, real-time quantitative PCR was used to compare mRNA levels (normalized log SQ mean) between the B 2 -VNTR and promoter control at various timepoints after the addition of transcriptional inhibitor actinomycin D, which was initially added at 48 h following transfection, denoted as time 0 (Fig. 6 ). These data were normalized by Renilla to control for transfection efficiency. With respect to mRNA decay, the calculated halflife of the B 2 -VNTR construct was significantly greater than that of the promoter control (B 2 -VNTR: 14.9 vs. promoter control: 12.2 h, Z ϭ Ϫ2.6; P ϭ 0.009). These data were qualitatively similar to that obtained for the respective constructs after transfection in Madine-Darby canine kidney (MDCK-2) cells (data not shown). These data do not suggest that an accelerated degradation of mRNA contributed to the observed reduction in reporter gene expression associated with the B 2 -VNTR.
B 2 -VNTR is associated with decreased polyadenylation of heterologous transcripts. To determine more precisely whether a posttranscriptional mechanism contributes to the effect of B 2 -VNTR to reduce luciferase activity, we measured total RNA and polyadenylated mRNA levels for each of the constructs. As summarized in Table 3 , total RNA (normalized SQ EMSA of B 2 -VNTR using nuclear and cytoplasmic protein extracts. To assess the capacity of the B 2 -VNTR region to bind proteins, we performed gel shift assays in which a biotinylated minimal B 2 -VNTR element (the 203-bp segment designated 12-REPEATS in Fig. 5 ) was exposed to both nuclear and cytoplasmic tsA201 protein extracts. As shown in Fig. 7A , the addition of the minimal B 2 -VNTR element to the nuclear proteins resulted in a specific band shift that was not observed with the addition of a comparably sized nonspecific competitor. In contrast, the pattern of banding was similar between the B 2 -VNTR and the competitor using cytoplasmic protein extracts (Fig. 7B) . These data suggest that the regulatory effect associated with the B 2 -VNTR may involve protein binding which occurs in the nuclear compartment.
Native B 2 receptor transcription is increased with cotransfection of the B 2 -VNTR. To determine whether the B 2 3Ј-UTR has the potential to affect endogenous B 2 receptor transcription, the B 2 -VNTR and promoter control were transiently transfected separately (n ϭ 5) in tsA201 cells, and the native B 2 receptor mRNA was measured using real-time quantitative PCR. Following normalization with GAPDH, native B 2 mRNA was increased by 43% (Z ϭ Ϫ2.0; P Ͻ 0.05) in cells transfected with the B 2 -VNTR compared with those transfected with promoter control (Table 4 ). These data suggest that the B 2 3Ј-UTR has the capacity to influence the regulation of the endogenous B 2 receptor.
DISCUSSION
In this study, we demonstrated that the human B 2 3Ј-UTR harbors elements that negatively regulate gene expression. We focused on the portion of the 3Ј-UTR (B 2 -VNTR) that contained a tandem repeats-type polymorphism that is flanked by AREs. Many studies demonstrated the importance of AREs as putative mediators of posttranscriptional and translational control (37, 38) . By binding trans-acting factors, such as hnRNPs and Hu proteins, AREs exert regulatory control of gene expression through rapid degradation of mRNAs and/or repression of translation (3) and operate in a context-and stimulusspecific manner (38) . In the current study, however, we detected no effects of the AREs contained in the B 2 -VNTR region to mediate or modify the observation of reduced luciferase expression. In contrast, we found that the VNTR segment of the B 2 3Ј-UTR itself accounted for the significant negative regulatory effect on reporter gene activity.
Regulatory sequences downstream of the promoter have the capacity to modulate transcriptional (8, 34) , posttranscriptional (24) , and even translational activity (21, 32, 39, 40) . For example, Carrion et al. (8) demonstrated the existence of a downstream regulatory element (DRE) sequence that mediates position-dependent, but orientation-independent, repression of prodynorphin gene transcription from its location in the 5Ј-UTR. Sanz et al. (34) reported an example of a DRE sequence, which is located downstream of the open reading frame in the 3Ј-UTR of the apoptotic hrk gene, that on binding a repressor protein results in transcriptional silencing. Analysis of the DRE sequence revealed a core GTCA sequence, similar to that found in CRE and AP-1 elements, which could also function in an inverse orientation (22) . In contrast to this situation, we found no evidence for a regulatory effect of a segment containing fewer than five copies of the core tandem repeat sequence of the B 2 -VNTR; however, the degree of repression was strongly positively correlated with the number of tandem repeats (Fig. 5) . Using a deletional analysis, we determined that the capacity of the B 2 -VNTR to repress gene expression was largely localized to the proximal portion of the element, and its effects, like the DRE sequence, were position dependent, but in contrast to the DRE sequence were more marked in the sense orientation.
To address more specifically the level at which the B 2 -VNTR acts to regulate gene expression, quantitative RT-PCR revealed that the total RNA level of the B 2 -VNTR construct was 32% of that of promoter control. With respect to the genomic structure of the B 2 receptor, the B 2 -VNTR occurs in the untranslated portion of the terminal exon, suggesting the Shown are total RNA and polyadenylated RNA levels for both the B2-VNTR construct and pGL3-Promoter (promoter control) and the ratio of total and polyadenylated RNA for the respective constructs. Results were normalized by cotransfected Renilla luciferase. possibility that the B 2 -VNTR could influence the 3Ј-end formation of mRNA. In support of this contention, our data showed that the B 2 -VNTR region had a marked effect on the efficiency of polyadenylation such that the number of polyadenylated RNA transcripts was 4% compared with control levels. Given the complexity of transcriptional regulation, additional studies are necessary to rule out the contribution of other transcript processing events. Taken together, these results are consistent with the hypothesis that the B 2 -VNTR acts at a point before the successful transport of transcripts into the cytoplasm. Indeed, our gel shift data showed that the B 2 -VNTR binds nuclear but not cytoplasmic protein extracts and supports the notion that the mechanism of the B 2 -VNTR to repress reporter gene expression occurs at a pretranslational level.
Somewhat surprisingly we found that the B 2 -VNTR was associated with increased mRNA stability (Fig. 6) , which suggests the possibility that the B 2 -VNTR can also affect translational events. Several studies demonstrated that untranslated regions, notably the 3Ј-UTR, can critically impact translational regulation (21, 32, 39, 40) . By virtue of the potential to bind trans-acting factors, in some cases directed by specific structural features, the 3Ј-UTR can act to either enhance or repress translation, the latter of which is exemplified in the 3Ј-UTR of the 15-lipoxygenase (15-lox) gene. Translational repression occurs in 15-lox by a mechanism that involves protein binding of heteronuclear RNP K and ␣-CP to a motif that is comprised of a pyrimidine-rich 19 nt tandem repeat located in the 3Ј-UTR (28).
Several aspects of B 2 receptor regulation have been well characterized. In studies of the rat B 2 promoter, factors such as cAMP (9, 11, 29) can transcriptionally increase B 2 receptor expression in a cell-specific manner and may contribute to the cytokine stimulation of the B 2 receptor by interleukin-1␤ (36) . Transcriptional control of the B 2 receptor may have particular relevance in the developing kidney where a complex regulatory role of p53 has been demonstrated (33) . A transcriptional silencing mechanism in the rat B 2 promoter has also been reported that is mediated by a putative SRE-1 site (2). In the context of inflammation, Lung et al. (24) characterized an upregulation of human B 2 receptor mRNA in response to interferon-␥ that was dependent on both transcriptional and posttranscriptional components.
In the current study, we addressed the potential for the B 2 -VNTR to affect endogenous regulation of the B 2 receptor. Cotransfection of the B 2 -VNTR in cells expressing the B 2 receptor (tsA201) was associated with a 43% increase in native B 2 receptor mRNA level. These results coupled with the gel-shift data that show binding of nuclear proteins to the B 2 -VNTR support the speculation that a nuclear protein(s) bound by the B 2 -VNTR has the capacity to negatively regulate events leading to the processing of mature mRNA transcripts.
It is unknown whether the mechanism by which the B 2 -VNTR segment regulates gene expression is applicable to other species or other genes. With respect to comparative genomics, the B 2 -VNTR segment in the human B 2 receptor is similar to that of the chimpanzee but displays little sequence conservation with the rat, mouse, or canine B 2 receptor sequences. Remarkably, as shown in Table 2 , a tandem repeat structure which bears considerable similarity to that of the B 2 -VNTR occurs in these latter species in alternate chromosomal locations, the significance of which awaits further study.
In summary, we identified a novel effect of the B 2 3Ј-UTR to act as a potent negative regulator of heterologous gene expression and provided data to support that the B 2 -VNTR modulates transcript-processing events such as polyadenylation which impact the efficiency of 3Ј-end formation. In addition, we identified the capacity for the B 2 -VNTR element to Fig. 7 . Nuclear and cytoplasmic electrophoretic mobility shift analysis (EMSA) of the B2-VNTR. EMSA was performed using a biotinlabeled minimal B2-VNTR probe (203 nt; 12-repeat construct shown in Fig. 6 ). A and B: labeled probe alone (free probe) is shown in lane 1. Lane 2 corresponds to the labeled probe incubated with tsA201 nuclear (A) and cytoplasmic (B) extracts. For competition experiments, nonlabeled B2-VNTR (lane 3) or nonspecific competitor (lane 4) was added in 10 -25 ϫ molar excess to protein extracts and incubated followed by the addition of labeled probe. Protein-DNA complexes were resolved by 5% polyacrylamide gel electrophoresis, transferred to a nylon membrane, and visualized on X-ray film. Shown is the RNA level for the B2 receptor for the B2-VNTR construct and pGL3-Promoter (promoter control) and the ratio of B2 receptor RNA after transfection with each of these constructs. Results were normalized by simultaneous measurement of GAPDH RNA levels.
participate in the regulation of the native B 2 receptor in a human kidney-derived cell line. Studies involving further fine localization of regulatory sequences in the B 2 -VNTR and identification of binding proteins will help address the relevant questions of whether the B 2 3Ј-UTR contributes to the endogenous regulation of the B 2 receptor in vivo and participates in kinin-dependent pathophysiology and also determine the generalizability of this 3Ј-UTR-based mechanism to the regulation of other genes.
